Brittany A Matthews1, Stephen J Kish1, Xin Xu1, Isabelle Boileau1, Pablo M Rusjan1, Alan A Wilson1, Dan DiGiacomo1, Sylvain Houle1, Jeffrey H Meyer2. 1. Research Imaging Centre and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. 2. Research Imaging Centre and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry and Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: jeff.meyer@camhpet.ca.
Abstract
BACKGROUND: Alcohol dependence (AD) is a multiorgan disease in which excessive oxidative stress and apoptosis are implicated. Monoamine oxidase A (MAO-A) is an important enzyme on the outer mitochondrial membrane that participates in the cellular response to oxidative stress and mitochondrial toxicity. It is unknown whether MAO-A levels are abnormal in AD. We hypothesized that MAO-A VT, an index of MAO-A level, is elevated in the prefrontal cortex (PFC) during AD, because markers of greater oxidative stress and apoptosis are reported in the brain in AD and a microarray analysis reported greater MAO-A messenger RNA in the PFC of rodents exposed to alcohol vapor. METHODS: Sixteen participants with alcohol dependence and 16 healthy control subjects underwent [(11)C]-harmine positron emission tomography. All were nonsmoking, medication- and drug-free, and had no other past or present psychiatric or medical illnesses. RESULTS: MAO-A VT was significantly greater in the PFC (37%, independent samples t test, t₃₀ = 3.93, p < .001), and all brain regions analyzed (mean 32%, multivariate analysis of variance, F₇,₂₄ = 3.67, p = .008). Greater duration of heavy drinking correlated positively with greater MAO-A VT in the PFC (r = .67, p = .005) and all brain regions analyzed (r = .73 to .57, p = .001-.02). CONCLUSIONS: This finding represents a new pathological marker present in AD that is therapeutically targetable through direct inhibition or by novel treatments toward oxidative/pro-apoptotic processes implicated by MAO-A overexpression.
BACKGROUND:Alcohol dependence (AD) is a multiorgan disease in which excessive oxidative stress and apoptosis are implicated. Monoamine oxidase A (MAO-A) is an important enzyme on the outer mitochondrial membrane that participates in the cellular response to oxidative stress and mitochondrial toxicity. It is unknown whether MAO-A levels are abnormal in AD. We hypothesized that MAO-A VT, an index of MAO-A level, is elevated in the prefrontal cortex (PFC) during AD, because markers of greater oxidative stress and apoptosis are reported in the brain in AD and a microarray analysis reported greater MAO-A messenger RNA in the PFC of rodents exposed to alcohol vapor. METHODS: Sixteen participants with alcohol dependence and 16 healthy control subjects underwent [(11)C]-harmine positron emission tomography. All were nonsmoking, medication- and drug-free, and had no other past or present psychiatric or medical illnesses. RESULTS:MAO-A VT was significantly greater in the PFC (37%, independent samples t test, t₃₀ = 3.93, p < .001), and all brain regions analyzed (mean 32%, multivariate analysis of variance, F₇,₂₄ = 3.67, p = .008). Greater duration of heavy drinking correlated positively with greater MAO-A VT in the PFC (r = .67, p = .005) and all brain regions analyzed (r = .73 to .57, p = .001-.02). CONCLUSIONS: This finding represents a new pathological marker present in AD that is therapeutically targetable through direct inhibition or by novel treatments toward oxidative/pro-apoptotic processes implicated by MAO-A overexpression.
Authors: Ingrid Bacher; Sylvain Houle; Xin Xu; Laurie Zawertailo; Alexandra Soliman; Alan A Wilson; Peter Selby; Tony P George; Julia Sacher; Laura Miler; Stephen J Kish; Pablo Rusjan; Jeffrey H Meyer Journal: Arch Gen Psychiatry Date: 2011-08
Authors: O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle Journal: J Cereb Blood Flow Metab Date: 2001-09 Impact factor: 6.200
Authors: Julia Sacher; Sylvain Houle; Jun Parkes; Pablo Rusjan; Sandra Sagrati; Alan A Wilson; Jeffrey H Meyer Journal: J Psychiatry Neurosci Date: 2011-11 Impact factor: 6.186
Authors: Alexandra Soliman; Chinelo Udemgba; Ian Fan; Xin Xu; Laura Miler; Pablo Rusjan; Sylvain Houle; Alan A Wilson; Jens Pruessner; Xiao-Ming Ou; Jeffrey H Meyer Journal: J Neurosci Date: 2012-11-28 Impact factor: 6.167
Authors: Nathan J Kolla; Brittany Matthews; Alan A Wilson; Sylvain Houle; R Michael Bagby; Paul Links; Alexander I Simpson; Amina Hussain; Jeffrey H Meyer Journal: Neuropsychopharmacology Date: 2015-06-17 Impact factor: 7.853
Authors: Jeremy W Duncan; Xiao Zhang; Niping Wang; Shakevia Johnson; Sharonda Harris; Chinelo Udemgba; Xiao-Ming Ou; Moussa B Youdim; Craig A Stockmeier; Jun Ming Wang Journal: Neuropharmacology Date: 2016-01-22 Impact factor: 5.250
Authors: Lina Chiuccariello; Robert G Cooke; Laura Miler; Robert D Levitan; Glen B Baker; Stephen J Kish; Nathan J Kolla; Pablo M Rusjan; Sylvain Houle; Alan A Wilson; Jeffrey H Meyer Journal: Int J Neuropsychopharmacol Date: 2015-08-27 Impact factor: 5.176